BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30211140)

  • 1. Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome.
    Mustapic S; Ziga S; Matic V; Bokun T; Radic B; Lucijanic M; Marusic S; Babic Z; Grgurevic I
    Can J Gastroenterol Hepatol; 2018; 2018():8490242. PubMed ID: 30211140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based Study.
    Ostovaneh MR; Zamani F; Ansari-Moghaddam A; Sharafkhah M; Saeedian FS; Rohani Z; Khoonsari M; Barzin G; Hemmasi G; Ajdarkosh H; Katoonizadeh A; Maadi M; Malekzadeh R; Poustchi H
    Metab Syndr Relat Disord; 2015 Sep; 13(7):304-11. PubMed ID: 26042518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
    Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
    Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation of risk factors between metabolic syndrome and nonalcoholic fatty liver disease in children and adolescents].
    Smolka V; Ehrmann J; Tkachyk O; Zápalka M
    Cas Lek Cesk; 2014; 153(2):91-7. PubMed ID: 24797780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity.
    OʼSullivan TA; Oddy WH; Bremner AP; Sherriff JL; Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Adams LA
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):624-31. PubMed ID: 24345826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of nonalcoholic fatty liver in prospective liver donors.
    Choudhary NS; Saraf N; Saigal S; Duseja A; Gautam D; Lipi L; Rastogi A; Goja S; Bhangui P; Ramchandra SK; Babu YR; Soin AS
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 27988988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause Does Not Affect Fatty Liver Severity In Women: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Osella AR; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Chiloiro M; Leandro G; Correale M; Tutino V; Misciagna G; Bonfiglio C; Caruso MG
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):513-521. PubMed ID: 29692271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
    Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
    García-Carretero R; Barquero-Pérez O; Mora-Jiménez I; Soguero-Ruiz C; Goya-Esteban R; Rodríguez-Castro C; Ramos-López J
    Hipertens Riesgo Vasc; 2019; 36(3):130-136. PubMed ID: 30655210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
    Kim D; Touros A; Kim WR
    Clin Liver Dis; 2018 Feb; 22(1):133-140. PubMed ID: 29128053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity.
    Jimenez-Rivera C; Hadjiyannakis S; Davila J; Hurteau J; Aglipay M; Barrowman N; Adamo KB
    BMC Pediatr; 2017 Apr; 17(1):113. PubMed ID: 28446162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between Cholecystectomy, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
    Latenstein CSS; Alferink LJM; Darwish Murad S; Drenth JPH; van Laarhoven CJHM; de Reuver PR
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00170. PubMed ID: 32352682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver.
    Sezgin O; Akpınar H; Özer B; Törüner M; Bal K; Bor S
    Turk J Gastroenterol; 2023 Jun; 34(6):652-664. PubMed ID: 37303246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
    Principi M; Iannone A; Losurdo G; Mangia M; Shahini E; Albano F; Rizzi SF; La Fortezza RF; Lovero R; Contaldo A; Barone M; Leandro G; Ierardi E; Di Leo A
    Inflamm Bowel Dis; 2018 Jun; 24(7):1589-1596. PubMed ID: 29688336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
    Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.